ArticleFrontiers in immunology2026

Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency.

Sule Haskologlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.